UCSD study finds surge in youth tobacco use tied to e-cigarettes

News
Jun.01.2022
AN DIEGO (CNS) – A UC San Diego study released Monday indicates a recent surge in young tobacco users in the U.S., most of whom are vaping e- cigarettes on a daily basis.

AN DIEGO (CNS) – A UC San Diego study released Monday indicates a recent surge in young tobacco users in the U.S., most of whom are vaping e- cigarettes on a daily basis.

In 2017, a 40% increase in US e-cigarette sales, which UCSD says was “driven by JUUL products,” coincided with a notable increase in young daily smokers.

UCSD says more than 1 million American youths between the ages of 14 and 17 years old became daily tobacco users within two years of 2017. By 2019, more than three quarters of those young smokers were vaping daily.

Study co-author and UCSD professor John Pearce said, “This rate of youth tobacco initiation has not been seen since the early 1990s, prior to the implementation of tobacco control measures. Given the recent evidence of the potential health consequences of vaping flavored e-cigarettes, this sharp rise among youth requires urgent public health attention and action.”

The study examined data from 2014, prior to the surge of JUUL products, and 2017, when a rise in JUUL sales was occurring.

Though the number of new cigarette smokers dropped during that span, overall daily tobacco usage increased, led by daily e-cigarette vaping, mostly among those between 14 and 17 years old.

“Three major contributors influenced the increase in daily e- cigarette usage: social media campaigns, high nicotine concentrations, and fruit flavors,” said senior author Karen Messer, Ph.D., professor of biostatistics at the Herbert Wertheim School of Public Health.

“Our prior research indicates that it is very difficult for dependent tobacco users to quit, with many e-cigarette users converting to cigarette smoking. This surge in dependent e-cigarette vaping may be reversing decades of decline in rates of tobacco addiction.”

Though the U.S. Food and Drug Administration announced a ban on most flavorings in e-cigarette cartridges in 2020, that policy did not include disposable e-cigarettes, e-liquids or refillable devices. UCSD says there were an estimated 1.7 million high-school aged children vaping last year, with 85% of them using flavored products.

 

Source:FOX5

 

UCSD study finds surge in youth tobacco use tied to e-cigarettes

 

 

 

AIR Invests $20 Million in Greentank, Deepening Capital Ties Across the Vape Supply Chain
AIR Invests $20 Million in Greentank, Deepening Capital Ties Across the Vape Supply Chain
Nasdaq-listed AIR Global has invested $20 million in preferred shares of Canadian vaporization technology company Greentank, deepening a partnership established in 2023. AIR gains a board nomination right, access to new technologies, enhanced commercial terms and long-term supply assurances, while retaining an option to increase its stake. Greentank’s Quantum Chip platform powers Crown Switch and forms part of AIR’s planned U.S. PMTA dossier, linking capital investment more closely with product technology, regulatory evidence and supply-chain control.
Special Report
Jul.29
Hawaii Restricts Vape Sales to FDA-Authorized Products, Disposable E-Cigarettes to Be Banned
Hawaii Restricts Vape Sales to FDA-Authorized Products, Disposable E-Cigarettes to Be Banned
Hawaii has enacted two new e-cigarette laws that significantly tighten market access requirements, requiring products to meet FDA authorization standards and banning disposable e-cigarette sales starting in 2027.
Jul.08
Product | KT&G Brings LOOP Nicotine Pouches to South Africa, Supporting ASF’s Expansion Across Africa
Product | KT&G Brings LOOP Nicotine Pouches to South Africa, Supporting ASF’s Expansion Across Africa
KT&G has introduced nicotine pouch brand LOOP in South Africa, expanding its modern oral nicotine portfolio. Developed by Swedish company Another Snus Factory (ASF), LOOP is a tobacco-free nicotine pouch brand. KT&G and U.S. tobacco company Altria previously participated in ASF’s strategic development, and the South Africa launch represents a further step in LOOP’s international expansion.
Aug.06
Special Report|AIR H1 Revenue Rises 3.7% as Shisha Volumes Fall 9%, Testing Its Shift Beyond Traditional Hookah
Special Report|AIR H1 Revenue Rises 3.7% as Shisha Volumes Fall 9%, Testing Its Shift Beyond Traditional Hookah
AIR’s first half-year results as a listed company offer a new test of how far a traditional hookah business can transform. H1 2026 revenue rose 3.7%, even as Flavored Shisha Molasses shipments fell 9%, with pricing and mix supporting growth. Traditional shisha still generates almost all revenue, while OOKA, Crown Switch, Greentank and U.S. regulatory spending point to accelerating diversification. The next test is whether those investments can become a second business of meaningful scale and profitability.
Capital Markets
Aug.21
Special Report | Russia, Ukraine and Belarus Launch Fresh Push to Rein in Vaping
Special Report | Russia, Ukraine and Belarus Launch Fresh Push to Rein in Vaping
Russia, Ukraine and Belarus are tightening vape regulation through different tools, from Ukraine’s stronger enforcement push and Belarus’s proposed advertising restrictions to Russia’s new GOST standard and regional sales-ban mechanism. As black-market concerns persist, some Russian experts argue that China’s tightly controlled but legalised model — built around licensing, traceability and taxation — may offer a more effective alternative to blanket prohibition.
Jul.15
Global Tobacco Control Faces Regional Adaptation Test as Nicotine Markets Evolve, Asian Specialist Says
Global Tobacco Control Faces Regional Adaptation Test as Nicotine Markets Evolve, Asian Specialist Says
As e-cigarettes, heated tobacco products and nicotine pouches expand across global markets, a central question is gaining urgency: can tobacco control rely on a universal policy model? In an interview with 2Firsts, Asian public health and addiction medicine specialist Dr. Rashidi Mohamed bin Pakri Mohamed says Western experience remains relevant, but policies must be adapted to local culture, healthcare systems, enforcement capacity, illicit markets and clinical evidence.
Jul.08